Immunogenicity of a tuberculosis DNA vaccine expressing a fusion protein Ag85B - MPB64 in mice
Author(s) -
Meng Xianying,
Lin Shan,
Qiang Zhang,
Li Qu,
Jie Li
Publication year - 2012
Publication title -
african journal of microbiology research
Language(s) - English
Resource type - Journals
ISSN - 1996-0808
DOI - 10.5897/ajmr12.1952
Subject(s) - immunogenicity , dna vaccination , mycobacterium tuberculosis , tuberculosis vaccines , vaccination , mycobacterium bovis , virology , tuberculosis , immune system , microbiology and biotechnology , bcg vaccine , immunology , medicine , biology , immunization , pathology
++ cells, and induced significantly higher levels of cell-mediated immune responses, as compared with vaccination with PBS or the pVAX1 empty vector. High levels of antibodies observed in the sera of immunized mice depicted strong humoral responses generated by DNA vaccine constructs. All the experimental vaccines imparted significant protection against challenge with M. tuberculosis H37Rv as compared to vector controls. These results show that the newly developed pMB vaccine may be used for the prevention and therapeutic intervention of MTb infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom